Back to Journals » Drug Design, Development and Therapy » Volume 14
Original Research
![Noteworthy comment: New findings in this paper are of clinician interest.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
12,332 | Dovepress* | 10,735+ | 1,859 | 12,594 | |
PubMed Central* | 1,597 | 505 | 2,102 | ||
Totals | 12,332 | 2,364 | 14,696 | ||
*Since 18 March 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
6 | 0 | 0 | 0 | 3 | 3 |
View citations on PubMed and Google Scholar